These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 354210)

  • 1. [Comparative analysis of haloperidol effect on depressive states in the early patients].
    Alkhimova LN
    Vrach Delo; 1978 May; (5):150-4. PubMed ID: 354210
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol.
    Cocito E; Ambrosini G; Arata A; Bevilacqua P; Tortora E
    Arzneimittelforschung; 1970 Aug; 20(8):1119-25. PubMed ID: 4921409
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative trial of low dose haloperidol and fluphenazine in office patients.
    Ayd FJ
    Dis Nerv Syst; 1972 Mar; 33(3):192-5. PubMed ID: 5022455
    [No Abstract]   [Full Text] [Related]  

  • 4. Depressive symptoms and schizophrenia a psychopharmacological approach.
    Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
    Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide.
    Palestine ML; Alatorre E
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):289-99. PubMed ID: 822987
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term haloperidol therapy in outpatients.
    Dunlop E
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:87-94. PubMed ID: 4862423
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experimentation with desipramine with statistical control].
    Kammerer M; Wartel R; Gurfein L; Weil J; Wysoki V; Gelb F
    Ann Med Psychol (Paris); 1968 Jan; 1(1):109-13. PubMed ID: 4870813
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J; Glitschka A; Müller K
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind comparison of pimozide and haloperidol in the treatment of recurrent anxiety states.
    Kenway AK
    Br J Clin Pract; 1973 Feb; 27(2):67-8. PubMed ID: 4577500
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmaco-clinical correlations during fluoxetine administration in patients with depressive schizophrenia treated with haloperidol decanoate].
    Viala A; Aymard N; Leyris A; Caroli F
    Therapie; 1996; 51(1):19-25. PubMed ID: 8762216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amoxapine as an antipsychotic: comparative study versus haloperidol.
    Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
    J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
    Jones B; Lehmann HE; Saxena BM; Ban TA
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):276-8. PubMed ID: 4969832
    [No Abstract]   [Full Text] [Related]  

  • 16. Ocular hypotensive effect of haloperidol.
    Sheppard J; Schaid DJ
    Trans Pa Acad Ophthalmol Otolaryngol; 1986; 38(1):362-70. PubMed ID: 3532444
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and effectiveness of haloperidol for mentally retarded behaviorally disordered and hyperkinetic patients.
    Grabowski SW
    Curr Ther Res Clin Exp; 1973 Nov; 15(11):856-61. PubMed ID: 4201599
    [No Abstract]   [Full Text] [Related]  

  • 18. A butyrophenone (haloperidol) for the treatment of institutionalized patients.
    Lapolla A; Nash LR
    Int J Neuropsychiatry; 1966 Apr; 2(2):129-34. PubMed ID: 5335397
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trials of viloxazine in depressive states].
    Fontan M; Goudemand M; Pellerin-Millecamps E
    Encephale; 1979; 5(3):243-9. PubMed ID: 385296
    [No Abstract]   [Full Text] [Related]  

  • 20. Amitriptyline and haloperidol in unstable and schizotypal borderline disorders.
    Soloff PH; George A; Nathan S; Schulz PM; Ulrich RF; Perel JM
    Psychopharmacol Bull; 1986; 22(1):177-82. PubMed ID: 3523575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.